Cerus Corporation has secured CE mark approval for its INT200, a LED-based illumination device, for the Intercept Blood ...

A ‘tumour-on-chip’ model on PDAC has been developed to allow insights into interactions between tumour cells and potential ...

C Medical Technologies has closed its Series D financing round. which was led by Boston Scientific, raising gross proceeds of ...

New York City’s Mount Sinai has become the first hospital in the US to perform a deep brain stimulation (DBS) implantation ...

Foresight Diagnostics has launched the PRECISE-HL trial, which will use the Foresight Clarity LDT to treat patients with ...

The European orphan drug market is growing and is already comparable in size and scope to the US market. The European Union ...

Post-authorisation safety studies (PASS) are often seen simply as a regulatory necessity, a checkbox that ensures ongoing ...

The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ issue with certain Baxter ...

Olympus is set to launch the Retentia HemoClip to assist gastrointestinal (GI) endoscopists in performing haemostasis.

Cadrenal Therapeutics has partnered with Abbott for the TECH-LVAD trial to assess the safety and efficacy of tecarfarin in ...

Epredia has received 510(k) clearance from the FDA for the E1000 Dx, a scanner designed to streamline laboratory cancer ...

GlobalData’s senior medical analyst says the ban will add to a downward trend for Illumina in the Chinese market.